Stay updated with breaking news from Mass Spec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
908 Devices Inc. (NASDAQ:MASS – Get Rating) CTO Christopher D. Brown sold 19,900 shares of the stock in a transaction on Friday, March 18th. The stock was sold at an average price of $20.06, for a total value of $399,194.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is […]
908 Devices (NASDAQ:MASS – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “908 Devices Inc. is a purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis. It conducts research, designs and […]
/PRNewswire/ -- LiVeritas Biosciences, Inc. (LiVeritas) today announced that it is now offering transformative mass spectrometry outsourcing solutions ("Mass...
/PRNewswire/ -- LiVeritas Biosciences, Inc. (LiVeritas) today announced that it is now offering transformative mass spectrometry outsourcing solutions ("Mass...
908 Devices (NASDAQ:MASS – Get Rating) released its earnings results on Monday. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.18) by $0.06, MarketWatch Earnings reports. 908 Devices had a negative return on equity of 17.50% and a negative net margin of 90.18%. The company […]